1. Home
  2. VYNE vs POAS Comparison

VYNE vs POAS Comparison

Compare VYNE & POAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VYNE Therapeutics Inc.

VYNE

VYNE Therapeutics Inc.

HOLD

Current Price

$0.68

Market Cap

22.3M

Sector

Health Care

ML Signal

HOLD

POAS

Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

N/A

Current Price

$2.51

Market Cap

22.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
VYNE
POAS
Founded
2003
2017
Country
United States
Singapore
Employees
10
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
22.3M
22.9M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
VYNE
POAS
Price
$0.68
$2.51
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
232.7K
1.3M
Earning Date
05-08-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.29
$0.53
52 Week High
$1.96
$7.40

Technical Indicators

Market Signals
Indicator
VYNE
POAS
Relative Strength Index (RSI) 66.11 62.18
Support Level $0.56 $1.40
Resistance Level $0.69 $3.84
Average True Range (ATR) 0.02 0.13
MACD 0.00 0.01
Stochastic Oscillator 88.82 79.98

Price Performance

Historical Comparison
VYNE
POAS

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.

About POAS Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.

Share on Social Networks: